Infant Shared Book Reading

Sponsor
University of Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT04337372
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
360
1
1
21.5
16.8

Study Details

Study Description

Brief Summary

Shared book reading has been found to have broad developmental benefits for language, socio-emotional and cognitive development. However, the effects of shared book reading on infant development are not well understood. Although healthcare professionals and educators ask parents to read books to their infants early and often, the book reading experience itself has never been systematically investigated in infancy. This work is guided by two specific aims and is expected to result in a better understanding of the effectiveness of shared book reading as a tool for supporting parent-infant interactions and infant learning across the first year of life. The first aim of the proposed research is to determine the extent to which infant and parent visual attentional coupling during shared book reading predicts later: a) infant selective attention and b) infant and parent neural coupling. The second aim of the proposed work is to determine the extent to which books with individually-named characters (e.g., "Boris", "Fiona") increases parent-infant joint attention and infant selective attention relative to books with generic labels (e.g., "Bear", "Bear") or no labels and whether attention differs by age. To address the aims of this project, a cross-sectional sample of 6-, 9-, and 12-month old infants and their parents will come to the laboratory and read a book that includes three distinct character labeling conditions (individual names, generic category labels, no label). During infant-parent shared book reading joint attention will be measured using dual eye-tracking. Infants and parents will then return to the lab the next day and infant selective attention and infant-parent neural synchrony will be measured using EEG frequency tagging while infants and their parent view familiar characters across labeling conditions as well as unfamiliar characters. If the aims of the proposed research are achieved, we will have determined the extent to which parent-infant joint attention prompts subsequent selective processing of book content in 6-, 9-, and 12-month old infants.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Book reading
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
360 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Parent-infant Learning Dynamics During Early Shared Book Reading
Actual Study Start Date :
Sep 15, 2021
Anticipated Primary Completion Date :
Mar 30, 2023
Anticipated Study Completion Date :
Jun 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Effects of shared book reading

There will be one arm since all participants will undergo the same intervention.

Behavioral: Book reading
Parent and their infant will read a short book in the laboratory. Books will include three labeling conditions expected to elicit different levels of attention.

Outcome Measures

Primary Outcome Measures

  1. Infant Visual Fixations [On Day 1]

    Infant visual fixations will be recorded during shared book reading and duration of attention and joint attention calculated. Three age groups will be examined (6-, 9-, and 12-month olds).

Secondary Outcome Measures

  1. Parent Visual Fixations [On Day 1]

    In the lab, parent visual attention will be measured across conditions using a head mounted eye-tracker. Duration of joint attention within a spatial window will be calculated in conjunction with infant visual fixations.

  2. Infant EEG steady-state evoked potential frequency tagging power [On Day 2]

    Infant EEG power will be measured and compared across conditions and ages during a ssVEP frequency tagging task. We will examine the ssVEP power evoked by two overlapping visual objects to quantify the degree of visual attention devoted to learned characters relative to novel characters across labeling conditions.

  3. Infant and parent EEG synchrony with steady-state evoked potential power [On Day 2]

    Infant and parent EEG synchrony will be quantified and compared across conditions.We will use magnitude squared coherence and phase-locking index to quantify EEG dyadic synchrony under viewing conditions in which the phase of brain oscillations is constrained by external stimulation (i.e., Steady-State Evoked Potential power (ssVEP) Frequency Tagging Task) and we will compare within-subject conditions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Months to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Infants will be included if they are typically developing and between 5.5 and 12.5 months of age, as well as their caregiver.

  • Parents 18-65 years old

Exclusion Criteria:
  1. Infants who were born more that 14 days premature.

  2. Infants who with a history of neurological or visual deficits.

  3. Infants with a history of seizures or a disorder that includes risk of seizures.

  4. Infants with a parent that has a history of seizures of a disorder that includes risk of seizures.

  5. Parents with a history of seizures or a disorder that includes risk of seizures.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Florida Brain, Cognition and Development Laboratory Gainesville Florida United States 32611-2250

Sponsors and Collaborators

  • University of Florida
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Lisa Scott, University of Florida
  • Principal Investigator: Andreas Keil, PhD, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT04337372
Other Study ID Numbers:
  • IRB202000756-N
  • 1R21HD102715-01
First Posted:
Apr 7, 2020
Last Update Posted:
Nov 18, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 18, 2021